Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Ambrx Biopharma Cayman, Inc.Listing unverified | BuyD (derivative) | $23.5M | SEC | ||
Ambrx Biopharma Cayman, Inc.Listing unverified | BuyD (derivative) | $356.9K | First in 12mo | SEC | |
Ambrx Biopharma Cayman, Inc.Listing unverified | BuyD (derivative) | $240.5K | SEC |